BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
8/21/19 AstraZeneca (AZN) Imfinzi for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
8/20/19 AstraZeneca (AZN) Farxiga for Congestive Heart Failure (CHF) and Cardiomyopathies Subscribers Only Subscribers Only Subscribers Only
8/20/19 NuCana (NCNA) Acelarin for Pancreatic Cancer Subscribers Only Subscribers Only Subscribers Only
8/19/19 Sarepta (SRPT) Vyondys 53 for Duchenne Muscular Dystrophy (DMD) Subscribers Only Subscribers Only Subscribers Only
8/19/19 Redx Pharma (AIM: REDX) RXC004 for Cancer Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
12/31/18 Subscribers Only Subscribers Only Trial Announcement - Initiation
08/16/19 Subscribers Only Subscribers Only Partnership - Acquisition Completion
08/24/19 Subscribers Only Subscribers Only Trial Data - Updated Results
08/27/19 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
Now - 08/28/19 Subscribers Only Subscribers Only Regulatory - Orphan Drug Designation (Europe)
Back to the top Back to the top